Arvinas (ARVN) Tax Provisions (2022 - 2026)
Arvinas (ARVN) posted quarterly Tax Provisions of $100000.0 for Q1 2026, down 50.0% year-over-year from $200000.0 in Q1 2025, and down 50.0% quarter-over-quarter from $200000.0 in Q4 2025.
Powered by 
Analysis
Arvinas (ARVN) Tax Provisions (2022 - 2026) Analysis & Trends
Arvinas' Tax Provisions history runs 5 years deep, the most recent figure standing at $100000.0 for Q1 2026.
- In Q1 2026, Tax Provisions fell 50.0% year-over-year to $100000.0; the TTM figure through Mar 2026 stood at $300000.0 (down 50.0% YoY), while the FY2025 annual figure was $300000.0, down 50.0% from the prior year.
- Tax Provisions for Q1 2026 stood at $100000.0, down from $200000.0 in the prior quarter.
- The five-year high for Tax Provisions was $10.8 million in Q4 2022, with the low at -$400000.0 in Q1 2023.
- The 5-year median for Tax Provisions is $200000.0 (2024), against an average of $1.4 million.
- The sharpest annual moves came in 2024 and 2025: Tax Provisions jumped 166.67% in 2024, then sank 250.0% in 2025.
- Arvinas' Tax Provisions stood at $10.8 million in 2022, then plunged by 85.19% to $1.6 million in 2023, then tumbled by 125.0% to -$400000.0 in 2024, then soared by 150.0% to $200000.0 in 2025, then slumped by 50.0% to $100000.0 in 2026.
- Business Quant data shows ARVN's Tax Provisions at $100000.0 in Q1 2026, $200000.0 in Q4 2025, and $300000.0 in Q3 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.31 Bn | 131.46 Bn | 2.84 Bn | 292.00 Mn |
| 2 | Regeneron Pharmaceuticals | 85.65 Bn | 77.66 Bn | 3.93 Bn | 230.90 Mn |
| 3 | Argenx Se | 63.46 Bn | 58.27 Bn | 1.37 Bn | -59.00 Mn |
| 4 | Moderna | 57.94 Bn | 52.80 Bn | 52.00 Mn | 15.00 Mn |
| 5 | Revolution Medicines | 44.05 Bn | 44.05 Bn | - | - |
| 6 | BeOne Medicines | 39.96 Bn | 34.86 Bn | 1.53 Bn | 75.45 Mn |
| 7 | Alnylam Pharmaceuticals | 35.16 Bn | 31.85 Bn | 992.69 Mn | 13.31 Mn |
| 8 | Royalty Pharma | 28.44 Bn | 27.60 Bn | - | - |
| 9 | Insmed | 27.32 Bn | 26.16 Bn | 358.27 Mn | 1.90 Mn |
| 10 | Arvinas | 609.44 Mn | 41.54 Mn | - | 200,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 200,000.00 |
| Mar 31, 2026 | 100,000.00 |
| Dec 31, 2025 | 200,000.00 |
| Sep 30, 2025 | 300,000.00 |
| Jun 30, 2025 | -300,000.00 |
| Mar 31, 2025 | 200,000.00 |
| Dec 31, 2024 | -400,000.00 |
| Sep 30, 2024 | 600,000.00 |
| Jun 30, 2024 | 200,000.00 |
| Mar 31, 2024 | 100,000.00 |
| Dec 31, 2023 | 1.60 Mn |
| Jun 30, 2023 | -300,000.00 |
| Mar 31, 2023 | -400,000.00 |
| Dec 31, 2022 | 10.80 Mn |
| Sep 30, 2022 | 2.20 Mn |
| Jun 30, 2022 | 3.40 Mn |
| Mar 31, 2022 | 4.50 Mn |